Effect	effect	O	O	O	O
of	of	O	O	O	O
some	some	O	O	O	O
convulsants	convulsants	O	O	OTHERS	I
on	on	O	O	O	O
the	the	O	O	O	O
protective	protective	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
loreclezole	loreclezole	O	O	OTHERS	I
and	and	O	O	O	O
its	its	O	O	O	O
combinations	combinations	O	O	O	O
with	with	O	O	O	O
valproate	valproate	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
clonazepam	clonazepam	O	O	OTHERS	I
in	in	O	O	O	O
amygdala-kindled	amygdala-kindled	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Loreclezole	loreclezole	O	O	OTHERS	I
(	(	O	O	O	O
5	5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
exerted	exerted	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
protective	protective	O	O	O	O
action	action	O	O	O	O
in	in	O	O	O	O
amygdala-kindled	amygdala-kindled	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
reducing	reducing	O	O	O	O
both	both	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
and	and	O	O	O	O
afterdischarge	afterdischarge	O	O	O	O
durations	durations	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
combinations	combinations	O	O	O	O
of	of	O	O	O	O
loreclezole	loreclezole	O	O	OTHERS	I
(	(	O	O	O	O
2.5	2.5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
with	with	O	O	O	O
valproate	valproate	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
clonazepam	clonazepam	O	O	OTHERS	I
,	,	O	O	O	O
or	or	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
applied	applied	O	O	O	O
at	at	O	O	O	O
their	their	O	O	O	O
subprotective	subprotective	O	O	O	O
doses	doses	O	O	O	O
)	)	O	O	O	O
also	also	O	O	O	O
exhibited	exhibited	O	O	O	O
antiseizure	antiseizure	O	O	O	O
effect	effect	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
test	test	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
only	only	O	O	O	O
two	two	O	O	O	O
first	first	O	O	O	O
combinations	combinations	O	O	O	O
occurred	occurred	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
of	of	O	O	O	O
pharmacodynamic	pharmacodynamic	O	O	O	O
nature	nature	O	O	O	O
.	.	O	O	O	O

Among	among	O	O	O	O
several	several	O	O	O	O
chemoconvulsants	chemoconvulsants	O	O	O	O
,	,	O	O	O	O
bicuculline	bicuculline	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
N-methyl-D-aspartic	n-methyl-d-aspartic	O	O	O	O
acid	acid	O	O	O	O
and	and	O	O	O	O
BAY	bay	O	O	OTHERS	I
k-8644	k-8644	O	O	OTHERS	I
(	(	O	O	O	O
the	the	O	O	O	O
opener	opener	O	O	O	O
of	of	O	O	O	O
L-type	l-type	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
channels	channels	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
reversed	reversed	O	O	O	O
the	the	O	O	O	O
protective	protective	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
loreclezole	loreclezole	O	O	OTHERS	I
alone	alone	O	O	O	O
and	and	O	O	O	O
its	its	O	O	O	O
combination	combination	O	O	O	O
with	with	O	O	O	O
valproate	valproate	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

On	on	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
hand	hand	O	O	O	O
,	,	O	O	O	O
bicuculline	bicuculline	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
aminophylline	aminophylline	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
BAY	bay	O	O	OTHERS	I
k-8644	k-8644	O	O	OTHERS	I
inhibited	inhibited	O	O	O	O
the	the	O	O	O	O
anticonvulsive	anticonvulsive	O	O	O	O
action	action	O	O	O	O
of	of	O	O	O	O
loreclezole	loreclezole	O	O	OTHERS	I
combined	combined	O	O	O	O
with	with	O	O	O	O
clonazepam	clonazepam	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
results	results	O	O	O	O
support	support	O	O	O	O
the	the	O	O	O	O
hypothesis	hypothesis	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
protective	protective	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
loreclezole	loreclezole	O	O	OTHERS	I
and	and	O	O	O	O
its	its	O	O	O	O
combinations	combinations	O	O	O	O
with	with	O	O	O	O
other	other	O	O	O	O
antiepileptics	antiepileptics	O	O	O	O
may	may	O	O	O	O
involve	involve	O	O	O	O
potentiation	potentiation	O	O	O	O
of	of	O	O	O	O
GABAergic	gabaergic	O	O	O	O
neurotransmission	neurotransmission	O	O	O	O
and	and	O	O	O	O
blockade	blockade	O	O	O	O
of	of	O	O	O	O
L-type	l-type	O	O	O	O
of	of	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
channels	channels	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

